Abnormal regional cerebral blood flow found by technetium-99m ethyl cysteinate dimer brain single photon emission computed tomography in systemic lupus erythematosus patients with normal brain MRI findings

Clinical Rheumatology

Volumn 21, Issue 6, 2002, Pages 516-519

  Chen, J J H ^a   Yen, R F ^b   Kao, albert ^a   Lin, C C ^a   Lee, C C ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

99mTc ethyl cysteinate dimer; Regional cerebral blood flow; Single photon emission computed tomography; Systemic lupus erythematosus

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN DISEASE; BRAIN INJURY; BRAIN PERFUSION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEADACHE; HUMAN; INTERMETHOD COMPARISON; MENTAL DISEASE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS; VERTIGO;

ADULT; CEREBROVASCULAR CIRCULATION; CYSTEINE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; ORGANOTECHNETIUM COMPOUNDS; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; SENSITIVITY AND SPECIFICITY; TELENCEPHALON; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036870108     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670200126     Document Type: Article

References (20)

1. Van Dam AP. Diagnosis and pathogenesis of CNS lupus. Rheumatol Int 1991;11:1-11.
2. Ellis SG, Verity MA. The central nervous system involvement in systemic lupus erythematosus. A review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum 1979;8:212-21.
3. Klippel JH, Zvaifler NJ. Neuropsychiatric abnormalities in systemic lupus erythematosus: an overview. Semin Arthritis Rheum 1986;15:185-99.
4. McCune WJ, MacGuire A, Aisen A, Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 1988;31:159-66.
5. 99m-HMPAO brain SPECT in systemic erythematosus with CNS involvement. J Nucl Med 1997;38:1112-15.
6. Kao CH, Ho YJ, Lan JL, Changlai SP, Liao KK, Chieng PU. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings. Arthritis Rheum 1999;42:61-8.
7. Kao CH, Lan JL, Changlai SP, Liao KK, Yen RP, Chieng PU. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus. Eur J Nucl Med 1999;26:129-34.
8. 99m d,1-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 1987;28:191-202.
9. 99m radiopharmaceuticals. Society of Nuclear Medicine. J Nucl Med 1998;39:923-6.
10. 99m-L,L-ECD for brain perfusion. Part 2. Biodistribution and brain imaging in humans. J Nucl Med 1989;30:1902-10.
11. 99m ECD brain SPECT in SLE patients with CNS involvement. Ann Nucl Med 2000;14:25-32.
12. Hughes RAC. Pathogenesis of neurological involvement in SLE. Lancet 1994;343: 580-1.
13. 99m-ECD: a comparison. J Nucl Med 1998;39:613-18.
14. 99m-ECD. J Nucl Med 1997;38:587-92.
15. 99m-ECD cerebral SPECT images in Alzheimer's disease. J Nucl Med 1996;37:1749-55.
16. 99m-HMPAO in healthy human subjects. J Nucl Med 1992;33:480-4.
17. Shen YY, Kao CH, Ho YJ, Lee JK. Regional cerebral blood flow in patients with systemic lupus erythematosus. J Neuroimaging 1999;9:160-4.
18. Hanly JG, Walsh NMG, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol 1992;19:732-41.
19. Devinsky O, Petitio CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli and thrombotic thrombocytopenia purpura. Ann Neurol 1988;1 23:380-4.
20. Carette S, Urowitz M, Grossman H, St Louis E. Cranial computerized tomography in systemic lupus erythematosus. J Rheumatol 1982;9:855-9.